Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

BURLINGTON, N.C. (WTVD) -- North Carolina-based LabCorp has received emergency use authorization from the Food and Drug Administration for a COVID-19 At-Home Test Kit. The kit allows for patients to ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...

A Labcorp team member draws blood from a patient.Labcorp Labcorp, one of the country’s largest providers of diagnostic ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of ...

Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator ...

Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management “Labcorp is the only reference laboratory to offer stinging insect (venom) component testing,” ...

Labcorp delivered mixed third-quarter results, with higher sales and raised profit | Labcorp reported solid third-quarter ...

BURLINGTON – Labcorp has opened a new testing program for cancer patients, sponsored by Eli Lilly and Company, which is also expanding its operations and footprint in North Carolina with a new ...